Patient safety issues in CKD: core curriculum 2015.
作者信息
Wagner Lee-Ann, Tata Asha L, Fink Jeffrey C
机构信息
Department of Medicine, University of Maryland School of Medicine, Baltimore, MD.
Division of Pharmacy Services, University of Maryland Medical Center, Baltimore, MD.
出版信息
Am J Kidney Dis. 2015 Jul;66(1):159-69. doi: 10.1053/j.ajkd.2015.02.343. Epub 2015 May 16.
Abstract
摘要
相似文献
1
Patient safety issues in CKD: core curriculum 2015.慢性肾脏病中的患者安全问题：2015年核心课程
Am J Kidney Dis. 2015 Jul;66(1):159-69. doi: 10.1053/j.ajkd.2015.02.343. Epub 2015 May 16.
2
What every doctor should know about drug safety in patients with chronic kidney disease.
Contrib Nephrol. 2015;184:24-50. doi: 10.1159/000365821. Epub 2015 Feb 9.
3
Effects of pharmacist participation in chronic kidney disease (CKD) network and CKD manual distribution on drug-related kidney injury.药师参与慢性肾脏病（CKD）网络和 CKD 手册分发对药物相关肾损伤的影响。
Pharmacoepidemiol Drug Saf. 2019 Jun;28(6):887-896. doi: 10.1002/pds.4787. Epub 2019 Apr 30.
4
Medication pitfalls in the CKD clinic: case presentations.慢性肾脏病临床中的用药误区：病例汇报。
Adv Chronic Kidney Dis. 2014 Jul;21(4):349-54. doi: 10.1053/j.ackd.2014.03.014.
5
Safety of medical therapy in patients with chronic kidney disease and end-stage renal disease.慢性肾脏病和终末期肾病患者药物治疗的安全性。
Curr Opin Nephrol Hypertens. 2014 May;23(3):306-13. doi: 10.1097/01.mnh.0000444912.40418.45.
6
Treatment of anemia with erythropoietin-stimulating agents in kidney transplant recipients and chronic kidney disease-another drawback of immunosuppression?肾移植受者和慢性肾脏病患者使用促红细胞生成素刺激剂治疗贫血——免疫抑制的另一个弊端？
Transplant Proc. 2012 Dec;44(10):3013-6. doi: 10.1016/j.transproceed.2012.06.070.
7
Medication Safety Principles and Practice in CKD.CKD 中的药物安全原则与实践。
Clin J Am Soc Nephrol. 2018 Nov 7;13(11):1738-1746. doi: 10.2215/CJN.00580118. Epub 2018 Jun 18.
8
Time to Reconsider Evidence for Anaemia Treatment (TREAT) = Essential Safety Arguments (ESA).重新审视贫血治疗证据的时机（TREAT）=基本安全论据（ESA）。
Nephrol Dial Transplant. 2010 Jun;25(6):1734-7. doi: 10.1093/ndt/gfq099. Epub 2010 Mar 2.
9
The end of the road for dual renin-angiotensin system blockade in diabetic nephropathy: which way now?糖尿病肾病中双重肾素-血管紧张素系统阻断的终结之路：现在何去何从？
Can J Diabetes. 2014 Oct;38(5):292-5. doi: 10.1016/j.jcjd.2014.05.005. Epub 2014 Aug 27.
10
Renoprotective effect of renin-angiotensin-aldosterone system blockade in patients with predialysis advanced chronic kidney disease, hypertension, and anemia.肾素-血管紧张素-醛固酮系统阻断在透析前晚期慢性肾脏病、高血压和贫血患者中的肾脏保护作用。
JAMA Intern Med. 2014 Mar;174(3):347-54. doi: 10.1001/jamainternmed.2013.12700.
引用本文的文献
1
Drug stewardship in chronic kidney disease to achieve effective and safe medication use.慢性病肾脏病中的药物管理以实现有效的、安全的药物使用。
Nat Rev Nephrol. 2024 Jun;20(6):386-401. doi: 10.1038/s41581-024-00823-3. Epub 2024 Mar 15.
2
A Patient Safety Educational Tool for Patients With Chronic Kidney Disease: Development and Usability Study.一种针对慢性肾脏病患者的患者安全教育工具：开发与可用性研究。
JMIR Form Res. 2020 May 28;4(5):e16137. doi: 10.2196/16137.
3
Medication decision-making for patients with renal insufficiency in inpatient and outpatient care at a US Veterans Affairs Medical Centre: a qualitative, cognitive task analysis.美国退伍军人事务医疗中心住院和门诊患者肾功能不全的药物决策：一项定性、认知任务分析。
BMJ Open. 2019 May 24;9(5):e027439. doi: 10.1136/bmjopen-2018-027439.
4
The use of nephrotoxic drugs in patients with chronic kidney disease.在慢性肾脏病患者中使用肾毒性药物。
Int J Clin Pharm. 2019 Jun;41(3):767-775. doi: 10.1007/s11096-019-00811-9. Epub 2019 Mar 21.
5
Evaluation of Renal Blood Flow in Chronic Kidney Disease Using Arterial Spin Labeling Perfusion Magnetic Resonance Imaging.使用动脉自旋标记灌注磁共振成像评估慢性肾脏病患者的肾血流
Kidney Int Rep. 2017 Jan;2(1):36-43. doi: 10.1016/j.ekir.2016.09.003. Epub 2016 Sep 13.
6
Association of Renal Elasticity and Renal Function Progression in Patients with Chronic Kidney Disease Evaluated by Real-Time Ultrasound Elastography.实时超声弹性成像评估慢性肾脏病患者肾脏弹性与肾功能进展的相关性。
Sci Rep. 2017 Feb 27;7:43303. doi: 10.1038/srep43303.
7
Nonsteroidal anti-inflammatory drug use in patients with chronic kidney disease.非甾体抗炎药在慢性肾脏病患者中的应用。
J Nephrol. 2017 Dec;30(6):781-786. doi: 10.1007/s40620-016-0352-z. Epub 2016 Sep 27.
本文引用的文献
1
Pain management in patients with chronic kidney disease.慢性肾病患者的疼痛管理
NDT Plus. 2009 Apr;2(2):111-8. doi: 10.1093/ndtplus/sfp001. Epub 2009 Jan 30.
2
Patiromer in patients with kidney disease and hyperkalemia receiving RAAS inhibitors.在接受 RAAS 抑制剂治疗的肾病和高钾血症患者中应用帕替络尔。
N Engl J Med. 2015 Jan 15;372(3):211-21. doi: 10.1056/NEJMoa1410853. Epub 2014 Nov 21.
3
Current status of nephrogenic systemic fibrosis.肾源性系统性纤维化的现状。
Clin Radiol. 2014 Jul;69(7):661-8. doi: 10.1016/j.crad.2014.01.003. Epub 2014 Feb 28.
4
Pain in chronic kidney disease: a scoping review.慢性肾脏病中的疼痛：一项范围综述
Semin Dial. 2014 Mar;27(2):188-204. doi: 10.1111/sdi.12196. Epub 2014 Feb 12.
5
Treatment with erythropoiesis-stimulating agents in chronic kidney disease patients with cancer.癌症合并慢性肾脏病患者的促红细胞生成素治疗。
Kidney Int. 2014 Jul;86(1):34-9. doi: 10.1038/ki.2013.528. Epub 2014 Jan 8.
6
Glucose-lowering drugs in patients with chronic kidney disease: a narrative review on pharmacokinetic properties.降糖药物在慢性肾脏病患者中的应用：药代动力学特征的叙述性综述。
Nephrol Dial Transplant. 2014 Jul;29(7):1284-300. doi: 10.1093/ndt/gft462. Epub 2013 Dec 8.
7
Medication dosing in patients with chronic kidney disease.慢性肾病患者的药物剂量
JAAPA. 2013 Oct;26(10):19-25. doi: 10.1097/01.JAA.0000435257.26357.a8.
8
Preventing stroke in patients with chronic kidney disease and atrial fibrillation: benefit and risks of old and new oral anticoagulants.
Stroke. 2013 Oct;44(10):2935-41. doi: 10.1161/STROKEAHA.113.001701. Epub 2013 Sep 5.
9
Risk of hyperkalemia in patients with moderate chronic kidney disease initiating angiotensin converting enzyme inhibitors or angiotensin receptor blockers: a randomized study.中度慢性肾脏病患者起始使用血管紧张素转换酶抑制剂或血管紧张素受体阻滞剂时高钾血症的风险：一项随机研究。
BMC Res Notes. 2013 Aug 1;6:306. doi: 10.1186/1756-0500-6-306.
10
Use of intravenous iron supplementation in chronic kidney disease: an update.慢性肾脏病中静脉补铁的应用：最新进展
Iran J Kidney Dis. 2013 Jan;7(1):9-22.
Zotero 插件